Aura Biosciences, Inc. (AURA)
NASDAQ: AURA · Real-Time Price · USD
6.91
-0.32 (-4.43%)
Aug 14, 2025, 11:52 AM - Market open
Aura Biosciences Market Cap
Aura Biosciences has a market cap or net worth of $429.25 million as of August 14, 2025. Its market cap has decreased by -16.37% in one year.
Market Cap
429.25M
Enterprise Value
289.93M
1-Year Change
-16.37%
Ranking
Category
Stock Price
$6.91
Market Cap Chart
Since the IPO on October 29, 2021, Aura Biosciences's market cap has increased from $397.73M to $429.25M, an increase of 7.92%. That is a compound annual growth rate of 2.03%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 12, 2025 | 430.31M | 4.80% |
| Dec 31, 2024 | 410.60M | -5.92% |
| Dec 29, 2023 | 436.44M | 12.22% |
| Dec 30, 2022 | 388.92M | -21.59% |
| Dec 31, 2021 | 496.00M | 24.71% |
| Oct 29, 2021 | 397.73M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 590.05B |
| Johnson & Johnson | 418.95B |
| AbbVie | 355.25B |
| UnitedHealth Group | 244.44B |
| AstraZeneca | 232.33B |
| Novartis AG | 230.64B |
| Abbott Laboratories | 225.16B |
| Novo Nordisk | 223.00B |